Saharinen Pipsa, Silvennoinen Olli
Haartman Institute, Department of Virology, Biomedicum Helsinki, Programme for Developmental and Reproductive Biology, University of Helsinki, Finland.
J Biol Chem. 2002 Dec 6;277(49):47954-63. doi: 10.1074/jbc.M205156200. Epub 2002 Sep 25.
Janus (Jak) tyrosine kinases contain a tyrosine kinase (JH1) domain adjacent to a catalytically inactive pseudokinase domain (JH2). The JH2 domain has been implicated in regulation of Jak activity, but its function remains poorly understood. Here, we found that the JH2 domain negatively regulates the activity of Jak2 and Jak3. Deletion of JH2 resulted in increased tyrosine phosphorylation of the Jak2- and Jak3-JH2 deletion mutants as well as of coexpressed STAT5. In cytokine receptor signaling, the deletion of the Jak2- and Jak3-JH2 domains resulted in interferon-gamma and interleukin-2-independent STAT activation, respectively. However, cytokine stimulations did not further induce the JH2 deletion mutant-mediated STAT activation. The deletion of the Jak2 JH2 domain also abolished interferon-gamma-inducible kinase activation, although it did not affect the reciprocal Jak1-Jak2 interaction in 293T cells. Chimeric constructs, where the JH2 domains were swapped between Jak2 and Jak3, retained low basal activity and cytokine inducible signaling, indicating functional conservation between the two JH2 domains. However, the basal activity of Jak2 was significantly lower than that of Jak3, suggesting differences in the regulation of Jak2 and Jak3 activity. In conclusion, we found that the JH2 domain has a conserved function in Jak2 and Jak3. The JH2 domain is required for two distinct functions in cytokine signaling: (i) inhibition of the basal activity of Jak2 and Jak3, and (ii) cytokine-inducible activation of signaling. The Jak-JH2 deletion mutants are catalytically active, activate STAT5, and interact with another Jak kinase, but the JH2 domain is required to connect these signaling events to receptor activation. Thus, we propose that the JH2 domain contributes to both the uninduced and ligand-induced Jak-receptor complex, where it acts as a cytokine-inducible switch to regulate signal transduction.
Janus(Jak)酪氨酸激酶包含一个与催化无活性的假激酶结构域(JH2)相邻的酪氨酸激酶(JH1)结构域。JH2结构域与Jak活性的调节有关,但其功能仍知之甚少。在这里,我们发现JH2结构域负向调节Jak2和Jak3的活性。JH2的缺失导致Jak2-和Jak3-JH2缺失突变体以及共表达的STAT5的酪氨酸磷酸化增加。在细胞因子受体信号传导中,Jak2-和Jak3-JH2结构域的缺失分别导致干扰素-γ和白细胞介素-2非依赖性的STAT激活。然而,细胞因子刺激并未进一步诱导JH2缺失突变体介导的STAT激活。Jak2 JH2结构域的缺失也消除了干扰素-γ诱导的激酶激活,尽管它不影响293T细胞中Jak1与Jak2的相互作用。嵌合构建体中,JH2结构域在Jak2和Jak3之间进行了交换,保留了低基础活性和细胞因子诱导的信号传导,表明两个JH2结构域之间存在功能保守性。然而,Jak2的基础活性明显低于Jak3,表明Jak2和Jak3活性调节存在差异。总之,我们发现JH2结构域在Jak2和Jak3中具有保守功能。JH2结构域在细胞因子信号传导中具有两个不同的功能:(i)抑制Jak2和Jak3的基础活性,以及(ii)细胞因子诱导的信号激活。Jak-JH2缺失突变体具有催化活性,激活STAT5,并与另一种Jak激酶相互作用,但JH2结构域是将这些信号事件与受体激活联系起来所必需的。因此,我们提出JH2结构域对未诱导的和配体诱导的Jak-受体复合物都有贡献,在其中它作为细胞因子诱导的开关来调节信号转导。